Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB1 | P08588 | 3/20 | 0.33 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.32 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.32 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.32 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.32 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.32 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3888868 | 1.00 | ADRB1 (0.33) | ADRB1GRIN2DGRIN3BCHRM2CHRM1 | |
| Bromide SCHEMBL4160212 | 0.97 | ADRB1 (0.32) | ADRB1GRIN2DGRIN3BCHRM2CHRM1 | |
| SCHEMBL14805909 | 0.97 | HIF1A (0.35) | ADRB1GRIN2DGRIN3BCHRM2CHRM1 | |
| Hydrochloric Acid SCHEMBL2422010 | 0.97 | HPGD (0.33) | ADRB1GRIN2DGRIN3BCHRM2CHRM1 | |
| SCHEMBL22375421 | 0.97 | HIF1A (0.35) | ADRB1GRIN2DGRIN3BCHRM2CHRM1 | |
| Methylamine SCHEMBL11757130 | 0.94 | GRIN2D (0.34) | ADRB1GRIN2DGRIN3BCHRM2CHRM1 | |
| SCHEMBL39972 | 0.89 | CXCR4 (0.35) | CHRM2CHRM1 | |
| SCHEMBL22096085 | 0.89 | — | — | |
| SCHEMBL25753249 | 0.89 | — | — | |
| Bicarbonate SCHEMBL6297564 | 0.87 | CA2 (0.38) | GRIN2DGRIN3BCHRM2CHRM1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4814 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119059990-B | Preparation method of 1-carbamic acid tert-butyl piperazine | 安徽昊帆生物有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-119059990-A | Preparation method of 1-carbamic acid tert-butyl piperazine | 安徽昊帆生物有限公司 | 2024-12-03 | — | — | CN | claimed |
| CN-114806414-B | Silicon polishing composition, preparation method and application thereof | 万华化学集团电子材料有限公司 | 2023-07-11 | — | — | CN | claimed |
| CN-114806414-A | Silicon polishing composition, preparation method and application thereof | 万华化学集团电子材料有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-114516642-A | MOR molecular sieve, and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2022-05-20 | — | — | CN | claimed |
| CN-103666604-B | Methanol gasoline stabilizer | SHANXI WHARTON IND CO LTD | 2015-05-13 | — | — | CN | claimed |
| US-20130245064-A1 | NOVEL NEUROTRYPSIN INHIBITORS | NEUROTUNE AG (CH) | 2013-09-19 | — | — | US | claimed |
| EP-2635554-A2 | NOVEL NEUROTRYPSIN INHIBITORS | Neurotune AG (CH) | 2013-09-11 | — | — | EP | claimed |
| WO-2012059443-A2 | NOVEL NEUROTRYPSIN INHIBITORS | NEUROTUNE AG (CH) | 2012-05-10 | — | — | WO | claimed |
| US-20020173607-A1 | Protected aminofunctionalized polymerization initiators and methods of making and using same | FMC CORPORATION | 2002-11-21 | — | — | US | claimed |
| US-4968676-A | PLANTS, SOILS, SEEDS | BASF AKTIENGESELLSCHAFT (DE) | 1990-11-06 | — | — | US | claimed |
| EP-4737470-A2 | C10-ALKYLENE SUBSTITUTED 13-MEMBERED MACROLIDES AND USES THEREOF | Zikani Therapeutics, Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| US-20260109712-A1 | RIFAMYCINS FOR NONTUBERCULOUS MYCOBACTERIA | UNIV MINNESOTA (US) | 2026-04-23 | — | — | US | disclosed |
| EP-4705291-A1 | IKK-ALPHA INHIBITORS | Cancer Research Technology Limited (GB) | 2026-03-11 | — | — | EP | disclosed |
| US-12552825-B2 | C10-alkylene substituted 13-membered macrolides and uses thereof | Zikani Therapeutics , Inc. (US) | 2026-02-17 | — | — | US | disclosed |
| EP-0034894-A2 | 2-(1-Piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives, processes for their preparation, intermediates used in the processes and the preparation thereof and pharmaceutical compositions containing the derivatives | AYERST, MCKENNA AND HARRISON INC. (CA) | 1981-09-02 | — | — | EP | disclosed |
| US-4210753-A | TREATMENT OF CARDIAC DISORDERS AND CHRONIC LUNG DISEASE | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1980-07-01 | — | — | US | disclosed |
| US-4038391-A | TRANQUILIZERS, ANTICONVULSANTS | RHONE-POULENC S.A. (FR) | 1977-07-26 | — | — | US | disclosed |
| US-4016274-A | TRANQUILIZERS AND ANTICONVULSANT AGENTS | RHONE-POULENC S.A. (FR) | 1977-04-05 | — | — | US | disclosed |
| US-3962248-A | PROCESS FOR MAKING 11-PIPERAZINO-DIAZEPINES, OXAZEPINES, THIAZEPINES AND AZEPINES | SANDOZ, INC. (US) | 1976-06-08 | — | — | US | disclosed |